Pat Zanzonico

Memorial Sloan Kettering Cancer Center

Papers

2

Total Citations

71

H-Index

2

About

Pat Zanzonico is a leading figure in preclinical molecular imaging, with a career dedicated to advancing the quantitative rigor of small-animal PET. His key research areas include tumor hypoxia imaging, image-guided intervention, and the validation of PET biomarkers through direct physiological measurement. Zanzonico’s major contributions lie in bridging the gap between noninvasive imaging and ground-truth biology. He pioneered the use of robotic systems to perform PET-guided intratumoral oxygen measurements, directly correlating parametric images from ¹⁸F-fluoromisonidazole (FMISO) with interstitial pO₂ probe data in rodent tumor models. This work, published in high-impact venues and cited over 70 times collectively, provided critical validation for FMISO as a hypoxia tracer and addressed longstanding concerns about its accuracy. By integrating kinetic analysis of dynamic PET data with precise, image-guided physical sampling, Zanzonico established a methodological gold standard for evaluating hypoxia imaging agents. His research has had a lasting impact on the field, offering a rigorous framework for translating preclinical imaging findings into clinically meaningful insights.

Research Focus

Key Achievements

2
H-Index
2
Papers
71
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Image-Guided Po<sub>2</sub> Probe Measurements Correlated with Parametric Images Derived from <sup>18</sup>F-Fluoromisonidazole Small-Animal PET Data in Rats
37 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago